Cargando…

Neutralizing Antibodies as Predictors of Vaccine Breakthrough Infection in Healthcare Workers Vaccinated with or without a Heterologous Booster Dose: A Cohort Study during the Third COVID-19 Wave in Peru

We evaluated neutralizing antibody (NAbs) levels as a protective factor against vaccine breakthrough infection (VBI) in healthcare workers (HCWs) during the third COVID-19 wave in Peru. This retrospective cohort study employed the information from a private laboratory in Lima (Peru) of HCW who recei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hueda-Zavaleta, Miguel, Gómez de la Torre, Juan C., Cáceres-DelAguila, José Alonso, Muro-Rojo, Cecilia, De La Cruz-Escurra, Nathalia, Copaja-Corzo, Cesar, Aragón-Ayala, Carlos J., Benítes-Zapata, Vicente A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961465/ https://www.ncbi.nlm.nih.gov/pubmed/36851324 http://dx.doi.org/10.3390/vaccines11020447

Ejemplares similares

Humoral Immune Response Induced by the BBIBP-CorV Vaccine (Sinopharm) in Healthcare Workers: A Cohort Study
por: Gómez de la Torre, Juan C., et al.
Publicado: (2022)

Humoral Response after a Fourth Dose with mRNA-1273 in Healthcare Workers with and without a History of SARS-CoV-2 Infection and Previously Vaccinated with Two Doses of BBIBP-CorV Plus BNT162b2 Vaccine
por: Gómez de la Torre, Juan C., et al.
Publicado: (2023)

Evaluation of the Humoral Immune Response of a Heterologous Vaccination between BBIBP-CorV and BNT162b2 with a Temporal Separation of 7 Months, in Peruvian Healthcare Workers with and without a History of SARS-CoV-2 Infection
por: Hueda-Zavaleta, Miguel, et al.
Publicado: (2022)

Antibiotic Use and Fatal Outcomes among Critically Ill Patients with COVID-19 in Tacna, Peru
por: Copaja-Corzo, Cesar, et al.
Publicado: (2021)

Clinical Characteristics Associated with Detected Respiratory Microorganism Employing Multiplex Nested PCR in Patients with Presumptive COVID-19 but Negative Molecular Results in Lima, Peru
por: Gómez de la Torre Pretell, Juan Carlos, et al.
Publicado: (2022)

Fetal death and its association with indicators of social inequality: 20-year analysis in Tacna, Peru
por: Copaja-Corzo, Cesar, et al.
Publicado: (2023)

Diagnostic performance of RT-PCR-based sample pooling strategy for the detection of SARS-CoV-2
por: Hueda-Zavaleta, Miguel, et al.
Publicado: (2022)

Predictors of Death in Patients with Neonatal Sepsis in a Peruvian Hospital
por: Vizcarra-Jiménez, Dariela, et al.
Publicado: (2022)

Factors Associated with Not Receiving a Booster Dose of COVID-19 Vaccine in Peru
por: Bendezu-Quispe, Guido, et al.
Publicado: (2022)

Determination of PaO2/FiO2 after 24 h of invasive mechanical ventilation and ΔPaO2/FiO2 at 24 h as predictors of survival in patients diagnosed with ARDS due to COVID-19
por: Hueda-Zavaleta, Miguel, et al.
Publicado: (2022)

Booster vaccines for COVID-19 vaccine breakthrough cases?
por: Nixon, Douglas F, et al.
Publicado: (2022)

Fruits and vegetables consumption and depressive symptoms: A population-based study in Peru
por: Wolniczak, Isabella, et al.
Publicado: (2017)

Homologous and Heterologous Covid-19 Booster Vaccinations
por: Atmar, Robert L., et al.
Publicado: (2022)

Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply
por: Krause, Philip R, et al.
Publicado: (2022)

Cerebral Cryptococcosis Associated with CD4+ T-lymphocytopenia in Non-HIV Patients after SARS-CoV-2 Infection: Case Series in a Specialized Institute in Lima, Peru
por: Huamani-Córdova, Juana M., et al.
Publicado: (2023)

Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection
por: Hyun, Hakjun, et al.
Publicado: (2023)

1467. Breakthrough Omicron Infections in Booster Vaccinated Healthcare Workers
por: Lee, Jeongjae, et al.
Publicado: (2022)

Factors associated with not receiving the primary series and booster dose of the COVID-19 vaccine among Venezuelan migrants in Peru: A population-based cross-sectional study
por: Al-kassab-Córdova, Ali, et al.
Publicado: (2023)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
por: Goh, Yun Shan, et al.
Publicado: (2022)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
Publicado: (2023)

Sleep Disorders and Their Associated Factors during the COVID-19 Pandemic: Data from Peruvian Medical Students
por: Copaja-Corzo, Cesar, et al.
Publicado: (2022)

Inequalities in COVID-19 vaccination coverage in Peru: An ecological study
por: Al-kassab-Córdova, Ali, et al.
Publicado: (2023)

Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report
por: Atmar, Robert L., et al.
Publicado: (2021)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

Breakthrough infections and acceptance of COVID-19 vaccine boosters: A survey analysis
por: Stevens, Christina W., et al.
Publicado: (2023)

Vaccine breakthrough infections with SARS-CoV-2: Why older adults need booster vaccinations
por: Ventura, Maria I., et al.
Publicado: (2022)

Heterologous booster COVID-19 vaccination elicited potent immune responses in HCWs
por: Saltoğlu, Neşe, et al.
Publicado: (2022)

Neutralizing antibodies induced by homologous and heterologous boosters in CoronaVac vaccines in Chile
por: Acevedo, Johanna, et al.
Publicado: (2023)

Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022
por: Park, Seon Kyeong, et al.
Publicado: (2023)

Association between Facebook Dependence and Poor Sleep Quality: A Study in a Sample of Undergraduate Students in Peru
por: Wolniczak, Isabella, et al.
Publicado: (2013)

Humoral and T Cell Immune Responses against SARS-CoV-2 after Primary and Homologous or Heterologous Booster Vaccinations and Breakthrough Infection: A Longitudinal Cohort Study in Malaysia
por: Fu, Jolene Yin Ling, et al.
Publicado: (2023)

Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections and vaccinees
por: YangYang, et al.
Publicado: (2022)

Nomophobia and Its Associated Factors in Peruvian Medical Students
por: Copaja-Corzo, Cesar, et al.
Publicado: (2022)

Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases
por: Fragoulis, George E, et al.
Publicado: (2022)

Heterologous COVID-19 Booster Vaccination in the Chronic Disorder of Consciousness: A Pilot Study
por: Pugliese, Maria Elena, et al.
Publicado: (2022)

Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
por: Ranzani, Otavio T., et al.
Publicado: (2022)

Prevalence and factors associated with not receiving the booster dose of the COVID-19 vaccine in adults in Latin America and the Caribbean
por: Urrunaga-Pastor, Diego, et al.
Publicado: (2022)

Prevalence of parents' non-intention to vaccinate their children and adolescents against COVID-19: A comparative analysis in Colombia and Peru
por: Benites-Zapata, Vicente A., et al.
Publicado: (2022)

Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
por: Kuhlmann, Constanze, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5cbrriqu5l5a6lnh01lijst56o